CPX101 or placebo 160mg Q2W

BIOLOGICAL2 trials

Sponsors

Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd.

Conditions

Overweight and Obesity

Phase 1

Safety, Tolerability, and Pharmacokinetics of a Single or Multiple Ascending Doses of CPX101

CompletedNCT06545162

Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd.Overweight and Obesity

Start: 2024-12-04End: 2025-12-30Updated: 2026-04-15

Phase 2

Evaluate the Safety and Efficacy of CPX101 in Overweight and Obese Subjects Without Diabetes Mellitus

CompletedNCT06532578

Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd.Overweight and Obesity

Start: 2024-08-13End: 2026-04-01Updated: 2026-04-15